Colorimetric quantification of mRNA expression in rare tumour cells amplified by multiple ligation-dependent probe amplification

Sanchez, Josep L. Acero; Henry, Olivier Y. F.; Mairal, Teresa; Laddach, Nadja; Nygren, Anders; Hauch, Siegfried; Fetisch, Jasmin; O'Sullivan, Ciara K.
July 2010
Analytical & Bioanalytical Chemistry;Jul2010, Vol. 397 Issue 6, p2325
Academic Journal
An enzyme-linked oligonucleotide assay (ELONA) for quantification of mRNA expression of five genes involved in breast cancer, extracted from isolated rare tumour cells and amplified by multiplex ligation-dependent probe amplification (MLPA) is presented. In MLPA, a multiplex oligonucleotide ligation assay is combined with a PCR reaction in which all ligation products are amplified by use of a single primer pair. Biotinylated probes complementary to each of the target sequences were immobilised on the surface of a streptavidin-coated microtitre plate and exposed to single-stranded MLPA products. A universal reporting probe sequence modified with horseradish peroxidase (URP–HRP) and complementary to a universal primer used during the MLPA step was further added to the surface-bound duplex as a reporter probe. Simultaneous addition of anchoring probe and target, followed by addition of reporter probe, rather than sequential addition, was achieved with no significant effect on sensitivity and limits of detection, but considerably reduced the required assay time. Detection limits as low as 20 pmol L−1, with an overall assay time of 95 min could be achieved with negligible cross-reactivity between probes and non-specific targets present in the MLPA-PCR product. The same MLPA-PCR product was analysed using capillary electrophoresis, the technique typically used for analysis of MLPA products, and good correlation was observed. The assay presented is easy to carry out, relatively inexpensive, rapid, does not require sophisticated instrumentation, and enables quantitative analysis, making it very promising for the analysis of MLPA products.


Related Articles

  • LAPTM4B GENE EXPRESSION AND POLYMORPHISM AS DIAGNOSTIC MARKERS OF BREAST CANCER IN EGYPTIAN PATIENTS. Shaker, Olfat; Taha, Fatma; Salah, Maha; El-Marzouky, Mohamed // Journal of Medical Biochemistry;Oct2015, Vol. 34 Issue 4, p393 

    Background: The aim of this study was to investigate the association between LAPTM4B gene polymorphism and the risk of breast cancer among Egyptian female patients. Also, measurement was done of its serum level to evaluate its significance as a diagnostic marker for breast cancer. Methods: This...

  • Serum Dickkopf-1 expression level positively correlates with a poor prognosis in breast cancer. Shao-jie Zhou; Shou-rong Zhuo; Xiao-qing Yang; Chun-xin Qin; Zi-liang Wang // Diagnostic Pathology;2014, Vol. 9 Issue 1, p1 

    Background The different expression level of Dickkopf-1 (DKK-1) in different cancers shows that the function of DKK-1 depends on the histological type of the cancer cells and the tissue microenvironment. To our knowledge, the serum expression level of DKK-1 in breast cancer is little known....

  • Gene expression profiling identifies Fibronectin 1 and CXCL9 as candidate biomarkers for breast cancer screening. Ruiz-Garcia, E.; Scott, V.; Machavoine, C.; Bidart, J. M.; Lacroix, L.; Delaloge, S.; Andre, F. // British Journal of Cancer;2/10/2010, Vol. 102 Issue 3, p462 

    Background:There is a need to develop blood-based bioassays for breast cancer (BC) screening. In this study, differential gene expression between BC samples and benign tumours was used to identify candidate biomarkers for blood-based screening.Methods:We identified two proteins (Fibronectin 1...

  • Biology -- Disease.  // Current Medical Literature: Breast Cancer;2006, Vol. 18 Issue 3, p69 

    The article provides an overview of citations about biological diseases. They include "Progression-Specific Genes Identified by Expression Profiling of Matched Ductal Carcinoma In Situ and Invasive Breast Tumors, Combining Laser Capture Microdissection and Oligonucleotide Microarray Analysis,"...

  • Converting a breast cancer microarray signature into a high-throughput diagnostic test. Glas, Annuska M; Floore, Arno; Delahaye, Leonie JMJ; Witteveen, Anke T; Pover, Rob CF; Bakx, Niels; Lahti-Domenici, Jaana ST; Bruinsma, Tako J; Warmoes, Marc O; Bernards, Rene; Wessels, Lodewyk FA; Van 't Veer, Laura J // BMC Genomics;2006, Vol. 7, p278 

    Background: A 70-gene tumor expression profile was established as a powerful predictor of disease outcome in young breast cancer patients. This profile, however, was generated on microarrays containing 25,000 60-mer oligonucleotides that are not designed for processing of many samples on a...

  • Molecular characteristics of recurrent triple-negative breast cancer. CHUNG-HSIN TSAI; JEN-HWEY CHIU; CHU-WEN YANG; JIR-YOU WANG; YI-FANG TSAI; LING-MING TSENG; WEI-SHONE CHEN; YI-MING SHYR // Molecular Medicine Reports;2015, Vol. 12 Issue 5, p7326 

    Due to the fact that the treatment of breast cancer depends significantly on the molecular markers present in the cancer, including estrogen receptor (+), progesterone receptor (+) or erbB2 receptor (+), further investigation targeting triple-negative breast cancer (TNBC) subtypes may assist in...

  • HspBP1 levels are elevated in breast tumor tissue and inversely related to tumor aggressiveness. Souza, Ana Paula; Albuquerque, Caroline; Torronteguy, Carolina; Frasson, Antonio; Maito, Fabio; Pereira, Luciana; Duval da Silva, Vinícius; Zerwes, Felipe; Raynes, Deborah; Guerriero, Vince; Bonorino, Cristina // Cell Stress & Chaperones;Autumn2009, Vol. 14 Issue 3, p301 

    HspBP1 is a co-chaperone that binds to and regulates the chaperone Hsp70 (Hsp70 is used to refer to HSPA1A and HSPA1B). Hsp70 is known to be elevated in breast tumor tissue, therefore the purpose of these studies was to quantify the expression of HspBP1 in primary breast tumors and in serum of...

  • Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients. Domschke, Christoph; Schuetz, Florian; Ge, Yingzi; Rom, Joachim; Zorn, Markus; Sinn, Hans-Peter; Marmé, Frederik; Schott, Sarah; Heil, Joerg; Scharf, Alexander; Sohn, Christof; Schneeweiss, Andreas; Beckhove, Philipp // Cancer Immunology, Immunotherapy;Mar2011, Vol. 60 Issue 3, p401 

    wide variety of cancer types has been associated with paraneoplastic autoimmune disorders and with the induction of autoimmunity against several autoantigens, among them self-antigens that are also expressed by tumor cells. This raises the question of autoimmune disorders as a result of immune...

  • Expression of Biologically Active Human Recombinant Interferon Alpha 2b in Human Breast Cancer Cell Line Bcap-37. Li, Hui; Li, Xiangping; Liu, Qingyou; Shi, Zhendan; Shi, Deshun // Applied Biochemistry & Biotechnology;Nov2013, Vol. 171 Issue 6, p1535 

    Human interferon alpha 2b (IFNα-2b) is a pleiotropic cytokine used to treat various viral diseases and cancers. Conventionally, recombinant human IFNα-2b used in clinics was produced by prokaryotic expression system, which always lack of enough biological activity due to limitations on...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics